{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T16:56:17Z","timestamp":1697388977893},"reference-count":18,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T00:00:00Z","timestamp":1242604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Factors predicting an unfavourable course of genital warts to treatment have not been determined.<\/jats:p><jats:p><jats:bold>Materials and methods\u2002<\/jats:bold> Behavioural and baseline disease characteristics were recorded from 246 males with anogenital warts. Urethral swabs were obtained and examined using the Hybrid Capture 2 Microplate assay. Patients were treated for their anogenital warts with cryotherapy, imiquimod cream 5% or podophyllotoxin. They were followed up every 3\u00a0months for 1 year.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Patients with a negative or low\u2010risk initial test tended to respond earlier to treatment than those with a high\/intermediate\u2010risk human papillomavirus (HPV) or with a dual infection (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.028). The response rate was unrelated (<jats:italic>P<\/jats:italic>\u00a0&gt;\u00a00.05) to the duration, number and anatomical location of the lesions and to the patient's age and sexual orientation, and only marginally to the initial extent of the lesion (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.046). However, the type of treatment predicted a favourable response (P\u00a0\u2264\u00a00.001), with patients who received both imiquimod and crotherapy responding worse. Considering all factors simultaneously in logistic regression, only the type of treatment and extent of the disease were found to influence the response rate.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> The type of treatment and extent of the disease were the only factors found critical for patients\u2019 response.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2009.03270.x","type":"journal-article","created":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T14:30:50Z","timestamp":1242657050000},"page":"1156-1160","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic factors for the response to treatment in males with genital warts"],"prefix":"10.1111","volume":"23","author":[{"given":"C","family":"Stefanaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Hadjivassiliou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Katzouranis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Bethimoutis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Nicolaidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Anyfantakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Lagogianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Caroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Panagiotopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Katsambas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,9,10]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70323-6"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.76.3.162"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.12.004"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.5858\/2003-127-940-HPTM"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2002.00366.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1258\/0956462011924218"},{"key":"e_1_2_5_8_2","first-page":"297","article-title":"Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomized observer blind placebo controlled study","volume":"67","author":"Handley JM","year":"1991","journal-title":"Genitourin Med"},{"key":"e_1_2_5_9_2","first-page":"389","article-title":"A randomized, double\u2010blind, parallel group study to compare subcutaneous interferon alpha 2a plus podophyllin in the treatment of primary condylomata acuminate","volume":"70","author":"Armstrong DKB","year":"1994","journal-title":"Genitourin Med"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1258\/095646207781024711"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/342109"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2004.10.020"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1258\/095646204774195173"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2007.007196"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.126579"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1258\/0956462054944390"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/030089160308900103"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-199807000-00003"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1258\/0956462991913457"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2009.03270.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2009.03270.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:41:35Z","timestamp":1697056895000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2009.03270.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1468-3083.2009.03270.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03270.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,10]]}}}